Last reviewed · How we verify
NCT06123312
Tri-modality Sampling Using Radial Probe Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Lesions
NA trial testing Tri-modality biopsy in Lung Nodule in 50 participants. Completed in 4 October 2024.
1 January 2024
Quick facts
| Lead sponsor | Pusan National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 50 |
| Start date | 1 November 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 4 October 2024 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Tri-modality biopsy
Conditions studied
- Lung Nodule — all drugs for Lung Nodule →
Sponsor
Pusan National University Hospital
Who can join
18 and older, any sex, with Lung Nodule. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
As the former radial probe endobronchial ultrasound (RP-EBUS) guided transbronchial forceps biopsy of peripheral pulmonary nodules has some limitations, the purpose of this study is to investigate a novel biopsy technique that combines forceps biopsy, needle aspiration, and transbronchial cryobiopsy in patients with peripheral pulmonary nodules.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cryobiopsy-Based Tri-Modality Sampling Using an Ultrathin Bronchoscope for the Diagnosis of Peripheral Lung Lesions: A Prospective Observational Study.
Seong H, Kim SH, Mok J, Kim MH, et al · · 2025 · PMID 40451176 · DOI 10.1159/000546433
Verify or expand the search:
- PubMed search for NCT06123312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Nodule
Currently open trials in the same condition.
- NCT06597968 — Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool · recruiting
- NCT07098884 — Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos · recruiting
- NCT06838806 — Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation · recruiting
- NCT06054854 — Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease) · recruiting
Other Pusan National University Hospital trials
Trials by the same sponsor.
- NCT07073365 — Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor The · Phase 2 · recruiting
- NCT06878495 — Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease · NA · not yet recruiting
- NCT06805123 — Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection · NA · recruiting
- NCT06752395 — Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions · NA · enrolling by invitation
- NCT07455552 — Comparison of Telemedicine-based and Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06123312 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pusan National University Hospital
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06123312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing